ArticlePloS one2025
Synergistic effects of notoginsenoside R1 and saikosaponin B2 in atherosclerosis: A novel approach targeting PI3K/AKT/mTOR pathway and macrophage autophagy.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- In Vitro Assessment of Antiviral Activity of Saikosaponin B2 Against Porcine Epidemic Diarrheal Virus.Viruses · 2026Article
- Mechanistic insights into PFAS derivatives-induced coronary heart disease and atherosclerotic renal artery stenosis via integrated network toxicology and molecular modeling.Toxicology research · 2026Article
- Plant-derived natural products targeting inflammation in treatment of atherosclerosis.Frontiers in pharmacology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atherosclerosis (AS) is a major global contributor to cardiovascular diseases and associated mortality. The traditional treatment primarily relies on statins; however, these drugs are often linked to side effects such as liver dysfunction and muscle impairment. Recent studies have highlighted the potential protective properties of saponin compounds derived from traditional herbal sources, such as notoginsenoside R1 (NGR1) and saikosaponin B2 (SSB2), in combating atherosclerosis. However, the comprehensive effects of these compounds against atherosclerosis and their underlying mechanisms remain inadequately understood. Firstly, we employed network pharmacology analysis to identify 113 common targets, including mTOR and CASP3, for NGR1, SSB2, and atherosclerosis from databases such as TCMSP. We constructed a protein-protein interaction (PPI) network and performed GO and KEGG enrichment analyses, whcih revealed key signaling pathways involved in PI3K/Akt, inflammation, and autophagy. The atherosclerosis model was established using ApoE-/- mice fed with a "Western diet" followed by treatment with NGR1, SSB2, or NS combination. Histological examinations, including hematoxylin-eosin (HE) staining, oil red O (ORO) staining, and CD68 immunofluorescence, were conducted to evaluate the pathological conditions of the aortic root, liver and kidneys in ApoE-/- mice. Our findings demonstrate that the NS combination improves lipid levels, lipid transport, and unstable plaque formation in ApoE-/- mice without adverse effects on liver or kidney function. Finally, oxidized low-density lipoprotein (ox-LDL) was used to culture RAW264.7 macrophages to establish an in vitro foam cell model. The effects of NS combination on lipid uptake, inflammatory response, apoptosis, the PI3K/Akt/mTOR signaling pathway, and autophagy were evaluated using methods such as CCK-8 assay, Oil Red O staining, immunofluorescence analysis, flow cytometry, RT-PCR, and Western blot analysis. The results indicated that NS combination promoted autophagy by inhibiting the PI3K/Akt/mTOR pathway. This significantly alleviated inflammation, reduced apoptosis, and decreasing lipid accumulation, thereby improving the pathological progression of atherosclerosis. Collectively, this study demonstrates, for the first time, that the NS combination synergistically activates macrophage autophagy by suppressing the PI3K/AKT/mTOR pathway, thereby attenuating lipid accumulation, inflammation, and apoptosis in atherosclerotic models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.